BRCA Variants Do Not Increase the Risk of Adverse Reactions in Patients With Ovarian Cancer: A Single-Center Real-World Study

BRCA Variants Do Not Increase the Risk of Adverse Reactions in Patients With Ovarian Cancer: A Single-Center Real-World Study

ObjectiveTo study the correlation between BRCA mutation status and the risk of adverse reactions in patients with ovarian cancer.MethodA real-world study was conducted at the largest gynecological oncology center in western China, the West China Second University Hospital of Sichuan University. The...

Full description

Bibliographic Details
Main Authors: Kemin Li, Jing Zeng, Mengpei Zhang, Rutie Yin, Zhengyu Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
ovarian cancer
BRCA
myelosuppression
allergies to chemotherapy drugs
real-world study
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.807748/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.807748/full

Similar Items